23 May 2013
Keywords: sr, pharma, loss, up, after, atugen, buy
Article | 03 July 2006
London, UK-headquartered drugmaker SR Pharma says that, for full-year 2005, its pretax losses deepened 20% on the previous year, to L3.6
million ($6.5 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 July 2006
© 2013 thepharmaletter.com